Tag: Amgen

LUMAKRAS FDA approval : Amgen bags approval in KRAS G12C-mutated NSCLC

businessnewstoday- May 29, 2021 0

LUMAKRAS FDA approval : Amgen has bagged accelerated approval from the US Food and Drug Administration (FDA) for LUMAKRAS (sotorasib) for the treatment of a ... Read More

Amgen to acquire Rodeo Therapeutics in $721m worth deal

businessnewstoday- March 31, 2021 0

Amgen has agreed to acquire Rodeo Therapeutics, a Seattle-based biopharma company, in a deal worth up to $721 million. Rodeo Therapeutics is engaged in developing ... Read More

Amgen to acquire Five Prime Therapeutics for gastric cancer candidate bemarituzumab

businessnewstoday- March 4, 2021 0

Amgen acquisition of Five Prime Therapeutics : Amgen has agreed to acquire Five Prime Therapeutics, a clinical-stage biotech company, for about $1.9 billion, to add ... Read More

Amgen gets breakthrough therapy status for sotorasib in China

pharmanewsdaily- January 31, 2021 0

Amgen said that sotorasib, an investigational KRASG12C inhibitor, has been given breakthrough therapy designation (BTD) from the Center for Drug Evaluation (CDE) of the National ... Read More

Lilly, Amgen collaborate to boost supply of potential COVID-19 therapies

pharmanewsdaily- September 17, 2020 0

Eli Lilly and Company has entered into a global antibody manufacturing collaboration with Amgen to considerably boost the supply capacity for its potential COVID-19 therapies. ... Read More

Janssen, Amgen secure FDA approval for DKd regiment in multiple myeloma

pharmanewsdaily- August 23, 2020 0

DKd regiment FDA approval for multiple myeloma : Janssen Pharmaceutical Companies of Johnson & Johnson and Amgen have been granted an expanded approval from the ... Read More

Amgen, Allergan file BLA to FDA for Rituxan biosimilar ABP 798

pharmanewsdaily- December 20, 2019 0

Rituxan biosimilar ABP 798 : US biopharma company Amgen and Irish pharma company Allergan have submitted a Biologics License Application (BLA) to the US Food ... Read More

Bristol-Myers Squibb wraps up $74bn acquisition of Celgene

pharmanewsdaily- November 22, 2019 0

Bristol-Myers Squibb has wrapped up its $74 billion acquisition of Celgene having got regulatory approval from all government authorities necessary for closing the merger agreement ... Read More

FTC clears decks for Bristol-Myers Squibb acquisition of Celgene

pharmanewsdaily- November 17, 2019 0

Bristol-Myers Squibb acquisition of Celgene : US pharma giant Bristol-Myers Squibb said that the US Federal Trade Commission (FTC) has given its clearance for its ... Read More

Amgen to take 20.5% stake in Chinese biotech company BeiGene for $2.7bn

pharmanewsdaily- November 5, 2019 0

US biopharma company Amgen has signed an all-cash deal to acquire a 20.5% stake in Chinese biotech company BeiGene for about $2.7 billion, as per ... Read More